Property:Outcome timeline
This is a property of type Text.
H
Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study +
T0: week -1 radiotherapy
T1: 3 months after radiotherapy (20 weeks after T0) +
Henning et al. (2015): Randomized Clinical Trial of Brewed Green and Black Tea in Men With Prostate Cancer Prior to Prostatectomy +
T0: Baseline
T1:
Green tea arm: after an average of 33 days
Black tea arm: after an average of 31 days
Water arm: after an average of 29 days +
Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy +
T0: baseline
T1: after 12 weeks
T2: after 24 weeks
T3: after 36 weeks
T4: after 52 weeks
T5: after 104 weeks +
Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine +
T0: Baseline
T1: 12th week
T2: 24th week
T3: 36th week
T4: 52nd week
T5: 104th week +
Hodgson et al. (2012): Reflexology versus Swedish Massage to Reduce Physiologic Stress and Pain and Improve Mood in Nursing Home Residents with Cancer: A Pilot Trial. +
T0: Early morning, 7-7:30 am;
T1: mid morning, 11-11:30 am;
T2: Early afternoon, 1-1:30 pm;
T3: late afternoon, 4-4:30 pm +
Hoopfer et al. (2015): Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy +
T0: baseline
T1: weekly until end of radiation
T2: week 1, 2, and 4 after end of radiation +
Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics +
Patients ingested the formulation pre-operatively daily for a minimum of 10 and a maximum of 21 days, dependent upon surgical scheduling. Plasma samples for PK assessment were obtained on days 1 and 2, and on the day of surgical resection. Plasma for PD assessment was obtained pre-dose, immediately prior to, and during surgery. Diseased and normal adjacent hepatic tissue was resected 6-7 h after the last dose. +
I
Inglis et al. (2020): Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT +
T0: basline
T1: week 12
T2: week 24 +
Iovino et al. (2018): High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation +
T0: first day of stem cell collection
T1: the day before the starting of the conditioning treatment
T2: day +30 after transplant
T3: day +100 after transplant +
J
Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study +
T0: Baseline
At 6, 12, 18 and 24 months +
Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial +
T0: Baseline (start of chemotherapy)
T1: End of chemotherapy (6 days)
T2: +1 day: transplantation
T3: 21 days after transplantation
T4: Follow-up after 3 months +
Jatoi et al. (2002): Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study +
T0: baseline
T1: end of study (no clear end of study defined) +
Jeon et al. (2016): Effect of intravenous high dose Vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trial +
T0: Baseline (pre-/peri-op)
T1: 2h post-op
T2: 6h post-op
T3: 24h post-op +
Johansson et al. (2021): Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial +
T0: Baseline
13 follow-up visits (4th, 8th, 12th, 16th, 20th, 24th, 28th, 32nd, 36th, 42nd, 48th, 54th, and 60th month) +
Johnson et al. (2010): Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain +
T0: baseline (2 days)
T1: after 7-10 days
T2: after 14-20 days +
Jyothirmayi et al. (1996): Efficacy of Vitamin A in the Prevention of Locoregional Recurrence and Second Primaries in Head and Neck Cancer +
T0: Baseline
T1: after three years +
K
Kadhim et al. (2021): Effect of Ginger Tea on Chemotherapy-Induced Nausea and Vomiting among Patients Attending the Oncology Teaching Hospital, Baghdad 2020 +
? +
Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 +
Study period: October 6, 2000 - November 5, 2009 +
Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer +
T0: Baseline
T1: day 9
T2: day 19
T3: day 45 +
Keshavarzi et al. (2019): The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer +
T0: baseline
T1: week 2
T2: week 4
T3: week 8 +